Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples